Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New agents for cytokine- and/or CAM-mediated disorders disclosed by Pfizer

Oct. 7, 1998

M-5011, a novel NSAID, shown to inhibit vertebral bone loss in arthritic rats

Oct. 6, 1998

Cell adhesion inhibitors developed by Sumitomo researchers

Oct. 2, 1998

MMP inhibitors from Bayer particularly useful for osteoarthritis and tumor metastasis

Oct. 2, 1998

Peptides that bind to MHC class II proteins in development at Zeneca

Oct. 1, 1998

Selectin inhibitors described by Sanwa Kagaku for inflammatory disorders

Oct. 1, 1998

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

NPS Pharmaceuticals initiates clinical trials for NPS-1776

Oct. 1, 1998

New arthritis Rx now available in Japan

Sep. 30, 1998

Selectin inhibitors under study at Kanebo

Sep. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...